PLAY PODCASTS
Contemporary Management of HIV 2021: New Data From IAS 2021—Audio Recap, Part 1
Episode 82

Contemporary Management of HIV 2021: New Data From IAS 2021—Audio Recap, Part 1

Listen as expert faculty discuss key studies influencing their practice following the IAS 2021 Conference, including results from studies on HIV and COVID-19 outcomes; virologic, metabolic, and safety outcomes of 2DR with DTG/3TC; long-acting CAB plus RPV for ART in treatment-naive and heavily treatment–experienced PWH; investigational antiretroviral agents, lenacapavir and islatravir; and alternative dosing of BPaL for MDR-TB.

Decera Clinical Education Infectious Disease Podcast · Shobha Swaminathan MD, Eric S Daar MD

September 8, 202129m 31s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this first of 2 episodes, Shobha Swaminathan, MD, and Eric S. Daar, MD, review key data influencing their practice following the IAS 2021 Conference, including results from studies on HIV and COVID-19 outcomes; virologic and metabolic outcomes of DTG/3TC; long-acting CAB plus RPV for ART in treatment-naive PWH.  

This episode includes discussion of:

  • A Global Clinical Platform that evaluated outcomes of PWH hospitalized with COVID-19
  • A post hoc analysis of TANGO, evaluating the virologic and metabolic outcomes when switching to DTG/3TC vs continued 3- or 4-drug TAF-based regimens
  • A Week 48 analysis of SALSA, demonstrating virologic efficacy and favorable safety profile of switching to DTG/3TC vs continuing a 3-drug ART regimen

Presenters:

Eric S. Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Shobha Swaminathan, MD
Associate Professor
Division of Infectious Diseases  
Department of Medicine
Rutgers New Jersey Medical School
Newark, New Jersey

Follow along with the slides at:
https://bit.ly/3hvRN5b

Content based on an online CME program supported by an educational grant from ViiV Healthcare.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

islatravirdolutegravirdoravirinebpalcabotegravirantiretroviralpeople with hivcabzenix2drdtgtreatment-naiveislflairdorarvpre-exposure prophylaxiscalibratelamivudine2-drug regimen3tcrpvlenacapavirpkantiretroviral therapypreppretomanidprotocol 016mdr-tbsalsalinezolidbedaquilineheavily treatment-experienced pwhcovid-19long-acting injectablecapellatuberculosislentangomultidrug resistant tuberculosisartpharmacokineticprotocol 011rilpivirinehtehivpwh